These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20190592)

  • 1. Comparing clinic retention between residents and nonresidents of Kibera, Kenya.
    Chung MH; Kohler P; Attwa M; Thiga J; John-Stewart GC
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):422-4. PubMed ID: 20190592
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing clinic retention between residents and nonresidents of Kibera, Kenya.
    Unge C; Södergård B; Ekström A; Carter J; Waweru M; Ilako F; Ragnarsson A; Marrone G; Thorson AM
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):283-4. PubMed ID: 19901845
    [No Abstract]   [Full Text] [Related]  

  • 3. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
    Burack G; Gaur S; Marone R; Petrova A
    J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study.
    Ekstrand ML; Chandy S; Heylen E; Steward W; Singh G
    J Acquir Immune Defic Syndr; 2010 Mar; 53(3):415-6. PubMed ID: 20190588
    [No Abstract]   [Full Text] [Related]  

  • 5. Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes?
    Zachariah R; Tayler-Smith K; Manzi M; Massaquoi M; Mwagomba B; van Griensven J; van Engelgem I; Arnould L; Schouten EJ; Chimbwandira FM; Harries AD
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):421-30. PubMed ID: 21724219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How long is the right interval for assessing antiretroviral pharmacy refill adherence?
    Acri TL; Grossberg RM; Gross R
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e16-8. PubMed ID: 20647824
    [No Abstract]   [Full Text] [Related]  

  • 7. [How and why should adherence to antiretroviral therapy].
    Knobel H
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):481-3. PubMed ID: 12433348
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors affecting adherence to antiretroviral therapy among children and adolescents living with HIV in the Mbita Sub-County Hospital, Homa Bay- Kenya.
    Tanyi WN; Gachuno O; Odero T; Farquhar C; Kimosop D; Mayi A
    Afr Health Sci; 2021 May; 21(Suppl):18-24. PubMed ID: 34447419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Controlled Trial of the Shikamana Intervention to Promote Antiretroviral Therapy Adherence Among Gay, Bisexual, and Other Men Who Have Sex with Men in Kenya: Feasibility, Acceptability, Safety and Initial Effect Size.
    Graham SM; Micheni M; Chirro O; Nzioka J; Secor AM; Mugo PM; Kombo B; van der Elst EM; Operario D; Amico KR; Sanders EJ; Simoni JM
    AIDS Behav; 2020 Jul; 24(7):2206-2219. PubMed ID: 31965432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic characteristics and opportunistic diseases associated with attrition during preparation for antiretroviral therapy in primary health centres in Kibera, Kenya.
    Tayler-Smith K; Zachariah R; Manzi M; Kizito W; Vandenbulcke A; Dunkley S; von Rege D; Reid T; Arnould L; Suleh A; Harries AD
    Trop Med Int Health; 2011 May; 16(5):579-84. PubMed ID: 21306485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antiretroviral drug therapy by adult patients attending HIV/AIDS clinic at a Kenyan tertiary health institution.
    Talam NC; Gatongi PM; Rotich JK; Kimaiyo S
    East Afr Med J; 2009 May; 86(5):240-3. PubMed ID: 20084993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007.
    Cornell M; Grimsrud A; Boulle A; Myer L
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):e102; author reply e102-3. PubMed ID: 21317578
    [No Abstract]   [Full Text] [Related]  

  • 13. "They just come, pick and go." The Acceptability of Integrated Medication Adherence Clubs for HIV and Non Communicable Disease (NCD) Patients in Kibera, Kenya.
    Venables E; Edwards JK; Baert S; Etienne W; Khabala K; Bygrave H
    PLoS One; 2016; 11(10):e0164634. PubMed ID: 27764128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old.
    Pardi GR; Nunes AA; Preto R; Canassa PG; Correia D
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):301-3. PubMed ID: 20118680
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana.
    Do NT; Phiri K; Bussmann H; Gaolathe T; Marlink RG; Wester CW
    AIDS Res Hum Retroviruses; 2010 Jun; 26(6):685-91. PubMed ID: 20518649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.
    Brown LB; Ayieko J; Mwangwa F; Owaraganise A; Kwarisiima D; Jain V; Ruel T; Clark T; Black D; Chamie G; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e15-e18. PubMed ID: 28394821
    [No Abstract]   [Full Text] [Related]  

  • 17. Taking care of the caretakers to enhance antiretroviral adherence in HIV-infected children and adolescents.
    Bryson Y
    J Pediatr (Rio J); 2014; 90(6):533-5. PubMed ID: 25128224
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya.
    Muhula SO; Peter M; Sibhatu B; Meshack N; Lennie K
    Pan Afr Med J; 2015; 20():63. PubMed ID: 26090021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.
    Mutasa-Apollo T; Shiraishi RW; Takarinda KC; Dzangare J; Mugurungi O; Murungu J; Abdul-Quader A; Woodfill CJ
    PLoS One; 2014; 9(1):e86305. PubMed ID: 24489714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is antiretroviral therapy adherence substantially worse on weekends than weekdays?
    Bachhuber M; Bilker WB; Wang H; Chapman J; Gross R
    J Acquir Immune Defic Syndr; 2010 May; 54(1):109-10. PubMed ID: 20418726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.